COMPARATIVE STUDY
EVALUATION STUDIES
JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Evaluation of a wearable body monitoring device during treadmill walking and jogging in patients with fibromyalgia syndrome.

OBJECTIVE: To evaluate the reliability and validity of a body monitoring device against measures obtained from indirect calorimetry (IC) in patients with fibromyalgia syndrome (FMS) during various incremental exercise intensities.

DESIGN: Cross-sectional reliability and validity study.

SETTING: Testing was completed in a university exercise physiology laboratory.

PARTICIPANTS: Women (N=25) with FMS, with a mean age ± SD of 48.6±8.4 years and a median symptom duration of 15 years (25th-75th percentiles, 10-23y), were recruited to the study.

INTERVENTIONS: Not applicable.

MAIN OUTCOME MEASURES: Patients walked and jogged on a treadmill at 4 intensities (50m·min(-1), 0% grade [n=25]; 83.3m·min(-1), 0% grade [n=25]; 116.7m·min(-1), 0% grade [n=21]; 116.7m·min(-1), 2.5% grade [n=13]) during 2 measurement conditions, while IC and a multiple-sensor body monitor measured energy expenditure (EE). The differences between the readings (test 1 - test 2) and the SD of the differences, intraclass correlation coefficient (ICC), 95% confidence interval (CI) for the ICC, coefficient of repeatability, intrapatient SD, standard error of mean (SEM), minimal detectable change, Wilcoxon signed-rank test, and Bland-Altman graphs were used to examine reliability. The magnitude of the associations between IC and the body monitoring device, ICC, 95% CI for the ICC, paired t tests, and Bland-Altman graphs were used to examine the validity of the body monitoring device versus the IC.

RESULTS: Moderate to excellent test-retest reliability was found for the 4 bouts of exercise (ICC=.73-.76). The SEM and minimal detectable change were satisfactory for the 4 bouts of exercise (.54-1.18kcal·min(-1) and 1.51-3.28kcal·min(-1), respectively). The differences mean between test and retest were lower than the SEM for the 4 bouts of exercise, varying from -.17 to .14kcal·min(-1). No significant differences were found between test and retest for any bout. The Bland-Altman plots and the coefficients of repeatability indicated that the differences between repeated tests would lie within 2 SDs in 95% of the cases for the 4 bouts of exercise. Significant associations were found between the body monitoring device and IC measurements of EE for the 4 bouts of exercise (r=.87-.99). The differences for all bouts between the 2 methods were nonsignificant, except for the second bout (P<.001). The ICCs and Bland-Altman plots of EE for the 4 bouts showed high agreement (ICCs=.84-.99) and sufficient accuracy for quantifying EE during exercise in patients with FMS.

CONCLUSIONS: The body monitoring device provided a valid and reliable estimate of EE in patients with FMS during walking on horizontal and inclined surfaces in a laboratory setting across various exercise intensities.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app